Lba02-04 interim results: a phase 2b trial of padeliporfin (wst11) vascular-targeted photodynamic therapy as partial-gland ablation for men with intermediate-risk prostate cancer

Journal of Urology(2020)

引用 1|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要